Al-Azzawi Farook, Barlow David, Hillard Tim, Studd John, Williamson Jenny, Rees Margaret
Menopause Int. 2007 Dec;13(4):178-81. doi: 10.1258/175404507783004168.
Osteoporosis affects one in three women. There has been some confusion among women and health professionals about the management of osteoporosis since the publication of the Women's Health Initiative and Million Women studies. This guidance regarding estrogen-based and non-estrogen-based treatments for osteoporosis responds to the controversies about the benefits and risks of individual agents. Treatment choice should be based on up-to-date evidence and targeted to individual women's needs.
骨质疏松症影响着三分之一的女性。自《妇女健康倡议》和《百万女性研究》发表以来，女性和健康专家对骨质疏松症的管理一直存在一些困惑。本关于基于雌激素和非雌激素的骨质疏松症治疗的指南回应了关于个别药物利弊的争议。治疗选择应基于最新证据，并针对个别女性的需求。
